Basic Research
Copyright ©The Author(s) 2004.
World J Gastroenterol. Aug 15, 2004; 10(16): 2344-2351
Published online Aug 15, 2004. doi: 10.3748/wjg.v10.i16.2344
Figure 3
Figure 3 PSCs were treated with IL-1β (at 2 ng/mL, lane 2) or HNE (at 5 μmol/L, lane 4) in serum-free medium for 1 h. Nuclear extracts were prepared and subjected to electro-phoretic mobility shift assay using AP-1 (panel A) or NF-κB (panel B) oligonucleotide probes. Arrows denote specific in-ducible complexes competitive with cold double-stranded oli-gonucleotide probes (lane 3). Lane 1: control (serum-free medium only). □: free probe.